OMEROS CORPORATION (OMER) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
OMEROS CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $4,149,000.00Net income (loss) → Operating adjustments reconciliation: $9,083,000.00OMIDRIA contract royalty asset → Operating adjustments reconciliation: $9,351,000.00Accounts payable and accrued expense → Operating adjustments reconciliation: $2,222,000.00Prepaid expenses and other → Operating adjustments reconciliation: $1,650,000.00Stock-based compensation expense → Operating adjustments reconciliation: $1,621,000.00Amortization of discount and issuance costs - Convertible Debt → Operating adjustments reconciliation: $1,437,000.00Non-cash interest remeasurement on OMIDRIA royalty obligation → Operating adjustments reconciliation: $557,000.00Depreciation and amortization → Operating adjustments reconciliation: $193,000.00Operating adjustments reconciliation → Remeasurement on fair value of financial instruments: $11,447,000.00Operating adjustments reconciliation → Receivables: $9,269,000.00Operating adjustments reconciliation → Non-cash interest on OMIDRIA contract royalty asset: $3,063,000.00Operating adjustments reconciliation → Remaining operating cash flows, net (calculated): $1,676,000.00Operating adjustments reconciliation → Inventory: $659,000.00Proceeds from the sale and maturities of investments → investing reconciliation: $13,600,000.00investing reconciliation → Net cash from investing activities: $3,400,000.00investing reconciliation → Purchases of investments: $10,155,000.00investing reconciliation → Purchases of property and equipment: $45,000.00Net cash used in financing activities → financing reconciliation: $7,467,000.00Exercise of stock options → financing reconciliation: $2,858,000.00financing reconciliation → Repurchases of common stock: $5,726,000.00financing reconciliation → Principal payments on OMIDRIA royalty obligation: $4,462,000.00financing reconciliation → Payments on finance lease obligations: $137,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $1,906,000.00Net cash from operating activities → Cash sources and uses: $4,149,000.00Net cash from investing activities → Cash sources and uses: $3,400,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $1,988,000.00Cash sources and uses → Net cash used in financing activities: $7,467,000.00Non-cash interest on OMIDRIA contract royalty asset: -$3,063,000.00Royalty asset interest, non-cash−$3.06 MNon-cash interest remeasurement on OMIDRIA royalty obligation: $557,000.00Royalty obligation interest+$557.00 KAmortization of discount and issuance costs - Convertible Debt: $1,437,000.00Debt cost amortization+$1.44 MOMIDRIA contract royalty asset: $9,351,000.00OMIDRIA contract royalty asset+$9.35 MPrepaid expenses and other: $1,650,000.00Prepaid & other assets+$1.65 MReceivables: -$9,269,000.00Receivables, net−$9.27 MInventory: -$659,000.00Inventories−$659.00 KAccounts payable and accrued expense: $2,222,000.00Payables & accrued liabilities+$2.22 MNet income (loss): $13,232,000.00Net income (loss)+$13.23 MStock-based compensation expense: $1,621,000.00Stock-based compensation+$1.62 MDepreciation and amortization: $193,000.00Depreciation & amortization+$193.00 KRemeasurement on fair value of financial instruments: -$11,447,000.00Derivative value change−$11.45 MRemaining operating cash flows, net (calculated): -$1,676,000.00Remaining operating (calculated)−$1.68 MNet cash from operating activities: $4,149,000.00Operating cash+$4.15 MOperating adjustments reconciliation: $26,114,000.00Repayment of 2026 Notes: $0.00Principal payments on OMIDRIA royalty obligation: -$4,462,000.00Royalty obligation repaid−$4.46 MRepurchases of common stock: -$5,726,000.00Common stock repurchases−$5.73 MNet share settlement of equity awards: $0.00Payments on finance lease obligations: -$137,000.00Finance lease payments−$137.00 KProceeds from issuance of common stock from the ATM facility, net: $0.00Payment of debt issuance costs related to 2029 Notes: $0.00Exercise of stock options: $2,858,000.00Exercise of stock options+$2.86 MNet cash used in financing activities: -$7,467,000.00. Cash required to fund net payments.Financing cash−$7.47 Mfinancing reconciliation: $10,325,000.00Proceeds from the sale and maturities of investments: $13,600,000.00Marketable securities proceeds+$13.60 MPurchases of investments: -$10,155,000.00Marketable securities purchases−$10.16 MPurchases of property and equipment: -$45,000.00PP&E purchases−$45.00 KNet cash from investing activities: $3,400,000.00Investing cash+$3.40 Minvesting reconciliation: $13,600,000.00Cash sources and uses: $9,455,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $1,906,000.00Beginning cash$1.91 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $1,988,000.00Ending cash$1.99 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$4.10 MOperating cash − cash spent on PP&ECash flow / Net income0.31×Operating cash flow ÷ net incomeNet cash change+$82.00 KEnding cash − beginning cash
Chart details

OMEROS CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
1,906,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
4,149,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Remeasurement of OMIDRIA contract royalty asset), so Remeasurement of OMIDRIA contract royalty asset and Loss on early extinguishment of Notes cannot be separated for this quarter. It may combine inflows and outflows.
Net income (loss)
13,232,000 US dollars
Non-cash interest on OMIDRIA contract royalty asset
negative 3,063,000 US dollars
Non-cash interest remeasurement on OMIDRIA royalty obligation
557,000 US dollars
Amortization of discount and issuance costs - Convertible Debt
1,437,000 US dollars
OMIDRIA contract royalty asset
9,351,000 US dollars
Prepaid expenses and other
1,650,000 US dollars
Receivables
negative 9,269,000 US dollars
Inventory
negative 659,000 US dollars
Accounts payable and accrued expense
2,222,000 US dollars
Stock-based compensation expense
1,621,000 US dollars
Depreciation and amortization
193,000 US dollars
Remeasurement on fair value of financial instruments
negative 11,447,000 US dollars
Remaining operating cash flows, net (calculated)
negative 1,676,000 US dollars
Investing activities
3,400,000 US dollars. Net cash provided.
Proceeds from the sale and maturities of investments
13,600,000 US dollars
Purchases of investments
negative 10,155,000 US dollars
Purchases of property and equipment
negative 45,000 US dollars
Financing activities
negative 7,467,000 US dollars. Net cash used.
Repayment of 2026 Notes
0 US dollars
Principal payments on OMIDRIA royalty obligation
negative 4,462,000 US dollars
Repurchases of common stock
negative 5,726,000 US dollars
Net share settlement of equity awards
0 US dollars
Payments on finance lease obligations
negative 137,000 US dollars
Proceeds from issuance of common stock from the ATM facility, net
0 US dollars
Payment of debt issuance costs related to 2029 Notes
0 US dollars
Exercise of stock options
2,858,000 US dollars
Operating adjustment reconciliation
26,114,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
10,325,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
13,600,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
1,988,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
9,455,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
82,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.31×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
4,149,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
45,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
4,104,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $4.15M of net income directly to operating cash and $9.08M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 4,149,000 US dollars minus 45,000 US dollars equals 4,104,000 US dollars.
OMEROS CORPORATION (OMER) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!